1. Home
  2. HOV vs CRVS Comparison

HOV vs CRVS Comparison

Compare HOV & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hovnanian Enterprises Inc.

HOV

Hovnanian Enterprises Inc.

HOLD

Current Price

$120.80

Market Cap

594.5M

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$6.78

Market Cap

546.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOV
CRVS
Founded
1959
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
594.5M
546.7M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
HOV
CRVS
Price
$120.80
$6.78
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$120.00
$13.75
AVG Volume (30 Days)
104.4K
1.7M
Earning Date
02-23-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
7.43
N/A
Revenue
$2,978,581,000.00
N/A
Revenue This Year
$7.30
N/A
Revenue Next Year
$4.88
N/A
P/E Ratio
$16.23
N/A
Revenue Growth
N/A
N/A
52 Week Low
$81.15
$2.54
52 Week High
$162.06
$9.60

Technical Indicators

Market Signals
Indicator
HOV
CRVS
Relative Strength Index (RSI) 64.33 36.31
Support Level $97.03 $6.45
Resistance Level $101.77 $7.18
Average True Range (ATR) 4.63 0.46
MACD 2.15 -0.08
Stochastic Oscillator 93.70 20.06

Price Performance

Historical Comparison
HOV
CRVS

About HOV Hovnanian Enterprises Inc.

Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations. The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments: Northeast, which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia, and West Virginia; Southeast, which includes Florida, Georgia, and South Carolina; and West, which includes Arizona, California, and Texas. The firm generates maximum revenue from the West Segment.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: